4古家大祜,四方贤一.糖尿病肾病の危险因子[J].Diabetes and Kidney Disease.Time to act(日本语翻译版),2003,1(1):17-25,33-39.
5Fried LF,Duckworth W,Zhang JH,et al.Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D)[J].Clinical Journal Of The American Society Of Nephrology,2009,4(2):361 -368.
6Thilly N,Bayat S,Alla F,et al.Determinants and patterns of reninangiotensin system inhibitors' prescription in the first year following kidney transplantation[J].Clinical Transplantation,2008,22(4):439 -446.
7Wang G,Lai FM,Lai KB,et al.Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephrepathy[J].Diabetologia.2008,51 (6):1062-1067.
8Balakumar P,Arora MK,Ganti SS,et al. Recent advances in pharmacotherapy for diabetic nephropathy: Current perspectives and future directions[ J ]. Pharmacol Res, 2009,60 ( 1 ) : 24 - 32.
9Navarro JF, Mora C, Macia M, et al. Infammatory parameters are independenty associated with nrinary albumin in Type 2 diabeties mellirus[ J ]. Am J Kidney Dis, 2003,42 ( 1 ):53 - 55.
